Based on 3 analysts giving stock ratings to Mesa Laboratories Inc in the past month.
In the current month, MLAB has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MLAB average Analyst price target in the last month is 125.000.
Based on analysts' estimates, MLAB EPS is projected to reach 0.360 in FY2027Q2, following reported EPS of 0.500 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.50, while Mesa Laboratories IncMLAB's earnings per share (EPS) for the previous quarter was USD -0.75. EPS for the next quarter is expected at USD 0.36.